Skip Main Navigation
Page Content

Thomas Lundbäck, AstraZeneca

Dr. Thomas Lundbäck has a broad network and extensive experience in the field of early drug discovery, with learnings from both the pharmaceutical industry and academia. He presently works as an Associate Director within the Innovative Medicines and Early Development organization at AstraZeneca in Gothenburg and as a Senior Advisor to the Chemical Biology Consortium Sweden team at Science for Life Laboratories and Karolinska Institutet. His personal research interest centers on the application of biophysical assays in primary cells to enable translation to patients.

Save This Event

Event Saved